Found: 25
Select item for more details and to access through your institution.
NFAT1 deficit and NFAT2 deficit attenuate EAE via different mechanisms.
- Published in:
- European Journal of Immunology, 2015, v. 45, n. 5, p. 1377, doi. 10.1002/eji.201444638
- By:
- Publication type:
- Article
Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy.
- Published in:
- Brain: A Journal of Neurology, 2016, v. 139, n. 10, p. 2617, doi. 10.1093/brain/aww189
- By:
- Publication type:
- Article
Human Brain Endothelial CXCR2 is Inflammation-Inducible and Mediates CXCL5- and CXCL8-Triggered Paraendothelial Barrier Breakdown.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 3, p. 602, doi. 10.3390/ijms20030602
- By:
- Publication type:
- Article
Fumaric Acid Esters Do Not Reduce Inflammatory NF-κB/p65 Nuclear Translocation, ICAM-1 Expression and T-Cell Adhesiveness of Human Brain Microvascular Endothelial Cells.
- Published in:
- International Journal of Molecular Sciences, 2015, v. 16, n. 8, p. 19086, doi. 10.3390/ijms160819086
- By:
- Publication type:
- Article
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Non-invasive assessment of retinal alterations in mouse models of infantile and juvenile neuronal ceroid lipofuscinosis by spectral domain optical coherence tomography.
- Published in:
- Acta Neuropathologica Communications, 2014, v. 2, n. 1, p. 1, doi. 10.1186/2051-5960-2-54
- By:
- Publication type:
- Article
OzEAN Study to Collect Real-World Evidence of Persistent Use, Effectiveness, and Safety of Ozanimod Over 5 Years in Patients With Relapsing-Remitting Multiple Sclerosis in Germany.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.913616
- By:
- Publication type:
- Article
Safety, Adherence and Persistence in a Real-World Cohort of German MS Patients Newly Treated With Ocrelizumab: First Insights From the CONFIDENCE Study.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.863105
- By:
- Publication type:
- Article
Natalizumab Exerts Direct Signaling Capacity and Supports a Pro-Inflammatory Phenotype in Some Patients with Multiple Sclerosis.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0052208
- By:
- Publication type:
- Article
Intrathecal, Polyspecific Antiviral Immune Response in Oligoclonal Band Negative Multiple Sclerosis.
- Published in:
- PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0040431
- By:
- Publication type:
- Article
Evaluation of Soluble Junctional Adhesion Molecule-A as a Biomarker of Human Brain Endothelial Barrier Breakdown.
- Published in:
- PLoS ONE, 2010, v. 5, n. 10, p. 1, doi. 10.1371/journal.pone.0013568
- By:
- Publication type:
- Article
Prolonged survival when temozolomide is added to accelerated radiotherapy for glioblastoma multiforme.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Altered motor plasticity in an acute relapse of multiple sclerosis.
- Published in:
- European Journal of Neuroscience, 2018, v. 47, n. 3, p. 251, doi. 10.1111/ejn.13818
- By:
- Publication type:
- Article
Novel insights into neuroinflammation: bacterial lipopolysaccharide, tumor necrosis factor α, and Ureaplasma species differentially modulate atypical chemokine receptor 3 responses in human brain microvascular endothelial cells.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Detection of intrathecal immunoglobulin G synthesis by capillary isoelectric focusing immunoassay in oligoclonal band negative multiple sclerosis.
- Published in:
- Journal of Neurology, 2016, v. 263, n. 5, p. 954, doi. 10.1007/s00415-016-8094-3
- By:
- Publication type:
- Article
Pathogenic inflammation in the CNS of mice carrying human PLP1 mutations.
- Published in:
- Human Molecular Genetics, 2016, v. 25, n. 21, p. 4686, doi. 10.1093/hmg/ddw296
- By:
- Publication type:
- Article
Interferon-β Is a Potent Inducer of Interferon Regulatory Factor-1/2-Dependent IP-10/CXCL10 Expression in Primary Human Endothelial Cells.
- Published in:
- Journal of Vascular Research, 2007, v. 44, n. 1, p. 51, doi. 10.1159/000097977
- By:
- Publication type:
- Article
Soluble VCAM-1 impairs human brain endothelial barrier integrity via integrin α-4-transduced outside-in signalling.
- Published in:
- Acta Neuropathologica, 2015, v. 129, n. 5, p. 639, doi. 10.1007/s00401-015-1417-0
- By:
- Publication type:
- Article
The Rare IL22RA2 Signal Peptide Coding Variant rs28385692 Decreases Secretion of IL-22BP Isoform-1, -2 and -3 and Is Associated with Risk for Multiple Sclerosis.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 1, p. 1, doi. 10.3390/cells9010175
- By:
- Publication type:
- Article
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.
- Published in:
- Journal of Neuroinflammation, 2016, v. 13, p. 1, doi. 10.1186/s12974-016-0719-z
- By:
- Publication type:
- Article
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients.
- Published in:
- Journal of Neuroinflammation, 2016, v. 13, p. 1, doi. 10.1186/s12974-016-0720-6
- By:
- Publication type:
- Article
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.
- Published in:
- 2016
- By:
- Publication type:
- journal article
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Atorvastatin partially prevents an inflammatory barrier breakdown of cultured human brain endothelial cells at a pharmacologically relevant concentration.
- Published in:
- Journal of Neurochemistry, 2007, v. 102, n. 4, p. 1001, doi. 10.1111/j.1471-4159.2007.04563.x
- By:
- Publication type:
- Article